MENU

Advances in Practical, Broad Coverage CFTR Testing with the AmplideX® PCR/CE CFTR Kit

Cystic fibrosis carrier screening is recommended for everyone, but today, 20 years after that recommendation, assays are optimized for a select group – that is largely people of European descent, which can leave people of other ethnic groups behind. There’s a simple reason for this gap – most tests are designed based on variant data that was gathered from almost exclusively European populations. We need to do better.

Register for on-demand webinars about:

  • Advances in CFTR testing for diverse populations based on recent, large-scale diverse data sets
  • Potential for comprehensive, yet streamlined workflow for three commonly analyzed genes (CFTR, SMN1/2, and FMR1)
  • Real-world lab challenges with genetic assays and how they were overcome

C.E. credit is available for all webinars.


You May Also Like

Agenda

  • JAN 20, 2022 1:30 PM EST

    How Did They Do It? Real-World Lab Journeys to Genetic Test Implementation

    Andrew Kincaid
    Senior Manager, Field Applications, Asuragen
    Tessa Gowan
    Field Application Scientist, Asuragen
    Stephanie Borel, MS
    Field Application Scientist, Asuragen
    Vivian Le
    Field Application Scientist, Asuragen
  • Comprehensive Yet Streamlined Genetic Testing with AmplideX® Technology
    JAN 20, 2022 12:30 PM EST

    Comprehensive Yet Streamlined Genetic Testing with AmplideX® Technology

    Ninad Pendsé, MS, MBA
    Senior Product Manager, Asuragen
    BIOGRAPHY
  • Practical CFTR Testing To Address Coverage Gaps with the AmplideX® PCR/CE CFTR Kit*
    JAN 20, 2022 11:00 AM EST

    Practical CFTR Testing To Address Coverage Gaps with the AmplideX® PCR/CE CFTR Kit*

    John N. Milligan, PhD
    Senior Manager, Research & Development, Asuragen
    BIOGRAPHY
Help

Loading Comments...